Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Hepatitis

Free Subscription Articles published in AIDS Retrieve available abstracts of 22 articles: HTML format

Single Articles

March 2023
1. DI SANDRO S, Catellani B, Guidetti C, Magistri P, et al
   Successful living donor liver transplantation from an HIV and HCV positive donor: report from the first case in the world.
   AIDS. 2023 Mar 6. doi: 10.1097/QAD.0000000000003533.
   PubMed     Abstract available
   
   
   January 2023
2. MOCROFT A, Geressu A, Beguelin C, Llibre JM, et al
   The role of HIV/hepatitis B virus/hepatitis C virus RNA+ triple infection in end-stage liver disease and all-cause mortality in Europe.
   AIDS. 2023;37:91-103.
   PubMed     Abstract available
   
   
   November 2022
3. SINGH KP, Pallett LJ, Singh H, Chen A, et al
   Pro-fibrogenic role of alarmin HMGB1 in HIV-HBV co-infection.
   AIDS. 2022 Nov 17. pii: 00002030-990000000-00152.
   PubMed     Abstract available
   
   
   September 2022
4. STONE J, Fraser H, Walker JG, Mafirakureva N, et al
   Modelling the impact of HIV and HCV prevention and treatment interventions among people who inject drugs in Kenya.
   AIDS. 2022 Sep 15. pii: 00002030-990000000-00111.
   PubMed     Abstract available
   
   
   February 2022
5. HAWKINS C, Kang M, Bhattacharya D, Cloherty G, et al
   Hepatitis B surface antigen and Hepatitis B RNA changes in HIV/HBV Co-infected participants receiving HBV-active antiretroviral therapy for 144 weeks.
   AIDS. 2022 Feb 14. pii: 00002030-900000000-96218.
   PubMed     Abstract available
   
   
   
6. SHAVER ZM, Anderson M, Bhebhe L, Baruti K, et al
   Decreased HBV vaccine response among HIV positive infants compared to HIV negative infants in Botswana.
   AIDS. 2022 Feb 1. pii: 00002030-900000000-96228.
   PubMed     Abstract available
   
   
   January 2022
7. ISFORDINK CJ, Smit C, Boyd A, de Regt MJA, et al
   Low HCV-viremia prevalence yet continued barriers to direct-acting antiviral treatment in people living with HIV in the Netherlands.
   AIDS. 2022 Jan 6. pii: 00002030-900000000-96245.
   PubMed     Abstract available
   
   
   November 2021
8. JEUDY J, Patel P, George N, Burrowes S, et al
   Assessment of coronary inflammation in antiretroviral treated people living with HIV infection and active HIV/HCV co-infection.
   AIDS. 2021 Nov 8. pii: 00002030-900000000-96274.
   PubMed     Abstract available
   
   
   October 2021
9. FURSA O, Mocroft A, Lazarus JV, Amele S, et al
   The hepatitis C cascade of care in HIV/HCV-coinfected individuals in Europe- regional and intra-regional differences.
   AIDS. 2021 Oct 25. pii: 00002030-900000000-96284.
   PubMed     Abstract available
   
   
   
10. QUINN JR, Goyal A, Ribeiro RM, Massaccesi G, et al
    Antiretroviral therapy for HIV and intrahepatic hepatitis C virus replication.
    AIDS. 2021 Oct 25. pii: 00002030-900000000-96283.
    PubMed     Abstract available
    
    
    September 2021
11. FRANCO S, Horneros J, Soldevila L, Ouchi D, et al
    Single nucleotide polymorphisms in PNPLA3, ADAR-1, and IFIH1 are associated with advanced liver fibrosis in patients co-infected with HIV-1/HCV.
    AIDS. 2021 Sep 2. pii: 00002030-900000000-96321.
    PubMed     Abstract available
    
    
    August 2021
12. MICAN R, Busca Arenzana C, Vasquez J, Daroca G, et al
    Hepatitis B reactivation after tenofovir withdrawal in an HIV-infected patient with history of cured hepatitis B virus infection and poor immunological status.
    AIDS. 2021;35:1707-1708.
    PubMed    
    
    
    
13. WINSLOW DL
    Hepatitis C virus infection and cardiac dysfunction in women.
    AIDS. 2021;35:1689-1690.
    PubMed    
    
    
    July 2021
14. PECHEUR EI
    Circulating micro-RNAs as biomarkers of liver fibrosis progression in hepatitis C virus/HIV-1-co-infected patients: a 'miR'-velous opportunity of early diagnosis?
    AIDS. 2021;35:1499-1500.
    PubMed    
    
    
    
15. RAMOS-RINCON JM, Pinargote H, Ramos-Belinchon C, de Mendoza C, et al
    Hepatitis delta in patients hospitalized in Spain (1997-2018).
    AIDS. 2021 Jul 13. pii: 00002030-900000000-96346.
    PubMed     Abstract available
    
    
    June 2021
16. GUARDIGNI V, Toschi A, Badia L, Del Turco ER, et al
    Patients living with HIV and cirrhosis: the risk for hepatocellular carcinoma after direct-acting antivirals for HCV.
    AIDS. 2021 Jun 4. pii: 00002030-900000000-96387.
    PubMed     Abstract available
    
    
    May 2021
17. CORMA-GOMEZ A, Macias J, Tellez F, Morano L, et al
    Kinetics of emergence of liver complications in HCV-infected patients and advanced fibrosis, with and without HIV-coinfection, after SVR.
    AIDS. 2021 May 27. pii: 00002030-900000000-96392.
    PubMed     Abstract available
    
    
    
18. HAMADY A, Cooke GS, Garvey LJ
    Identification of hepatitis delta superinfection when investigating transaminitis in HIV/HBV coinfection.
    AIDS. 2021 May 10. pii: 00002030-900000000-96410.
    PubMed     Abstract available
    
    
    
19. CHADWICK D, Forbes G, Lawrence C, Lorrimer S, et al
    Using an electronic health record alert to prompt blood-borne virus testing in primary care.
    AIDS. 2021 May 10. pii: 00002030-900000000-96408.
    PubMed     Abstract available
    
    
    April 2021
20. HUNG R, Patel N, Fox J, Cosgrove C, et al
    Prevalence of HIV/hepatitis B and HIV/hepatitis C coinfection among people of East, South, Central and West African ancestry in the United Kingdom.
    AIDS. 2021 Apr 28. pii: 00002030-900000000-96416.
    PubMed     Abstract available
    
    
    
21. SHITOLE SG, Lazar JM, Hanna DB, Kim RS, et al
    HIV, HCV and risk of new-onset left ventricular dysfunction: the women's interagency HIV study.
    AIDS. 2021 Apr 15. pii: 00002030-900000000-96421.
    PubMed     Abstract available
    
    
    March 2021
22. FRANCO S, Buccione D, Tural C, Martinez MA, et al
    Circulating microRNA signatures that predict liver fibrosis progression in patients with HIV-1/HCV co-infections.
    AIDS. 2021 Mar 31. pii: 00002030-900000000-96441.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: